Mesdopetam

DB16229InvestigationalSmall molecule

Mesdopetam is under investigation in clinical trial NCT04435431 (A Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia).

Mechanism: Pharmacologically active on Dopamine receptor D3
Curator reviewed
Formula / weight: C₁₂H₁₈FNO₃S · 275.34 g/mol (avg)
Code names: IRL-790

Resolves to

Compound

UNIIHD4QV8GX26CAS1403894-72-3

Structure

InChIKeyOSBPYFBXSLJHCR-UHFFFAOYSA-NSMILESCCCNCCOC1=CC(=CC(F)=C1)S(C)(=O)=O

Targets

P35462DRD3

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Mesdopetam, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account